Top Markets
Coin of the day
Molecular Pharmacology (USA), Ltd. Molecular Pharmacology (USA), Ltd.

Molecular Pharmacology (USA), Ltd.

MLPH
株式のランク #39112
As a development-stage company, Molecular Pharmacology (USA) Limited (MLPH) is... As a development-stage company, Molecular Pharmacology (USA) Limited (MLPH) is dedicated to the creation and market introduction of solutions for pain and inflammation, with a primary focus on the Australian and United States markets. Through its subsidiary, Molecular Pharmacology Pty. Ltd., it is advancing an analgesic and anti-inflammatory molecule called Tripeptofen, designed to alleviate common daily pain. These products are offered in diverse dosage forms, formulations, and packaging options to suit various needs. MLPH's marketing strategy involves leveraging pharmaceutical distributors and forging collaborative partnerships with companies in the United States and Europe. Additionally, the company maintains an agreement with Dermatology Development Corporation to jointly develop and market a suite of therapeutic, cosmetic, and cosmeceutical items derived from the ThermaLIFE product line and its core active component. Headquartered in Perth, Australia, Molecular Pharmacology (USA) Limited operates as a subsidiary of PharmaNet Group Limited.
株価
$0.0322
最終同期: 2026-08-11
時価総額
$643.71K
変化(1日)
0.00%
変化(1年)
544.00%
AU
取引 Molecular Pharmacology (USA), Ltd. (MLPH)

カテゴリー

Molecular Pharmacology (USA), Ltd.(MLPH)の株価履歴
終値の最高値: $0.03 (2026-08-01)

終値の最安値: $0.47 (2009-07-01)
Molecular Pharmacology (USA), Ltd. の株価履歴(2009 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 57.98%
2025 300.00%
2024 -86.58%
2023 27.20%
2022 485.71%
2021 -95.90%
2020 31.25%
2019 -32.31%
2018 100.97%
2017 14.79%
2016 -83.06%
2015 -16.84%
2014 -47.72%
2013 50.34%
2012 720.91%
2011 -87.47%
2010 -59.86%
2009 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$503.68 29.05%
US
$840.68 28.85%
NL
$725.45 6.21%
CH
$1.07K -6.40%
KR
$252.06 11.35%
BE